▶ 調査レポート

世界の免疫タンパク質診断検査市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Immunoprotein Diagnostic Testing Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の免疫タンパク質診断検査市場規模・現状・予測(2021年-2027年) / Global Immunoprotein Diagnostic Testing Market Size, Status and Forecast 2021-2027 / QYR2104Z3060資料のイメージです。• レポートコード:QYR2104Z3060
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、95ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥546,000 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥819,000 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,092,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、免疫タンパク質診断検査のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(C反応性タンパク質診断検査、補体系タンパク質診断検査、プレアルブミン診断検査、ハプトグロビン診断検査、免疫グロブリン診断検査、遊離軽鎖診断検査、その他)、用途別市場規模(自己免疫検査、感染症検査、アレルギー検査、内分泌検査、腫瘍検査、毒性検査、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・免疫タンパク質診断検査の市場動向
・企業の競争状況、市場シェア
・免疫タンパク質診断検査の種類別市場規模(C反応性タンパク質診断検査、補体系タンパク質診断検査、プレアルブミン診断検査、ハプトグロビン診断検査、免疫グロブリン診断検査、遊離軽鎖診断検査、その他)
・免疫タンパク質診断検査の用途別市場規模(自己免疫検査、感染症検査、アレルギー検査、内分泌検査、腫瘍検査、毒性検査、その他)
・免疫タンパク質診断検査の北米市場規模2016-2027(アメリカ、カナダ)
・免疫タンパク質診断検査のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・免疫タンパク質診断検査のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・免疫タンパク質診断検査の中南米市場規模2016-2027(メキシコ、ブラジル)
・免疫タンパク質診断検査の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Beckman Coulter、DiaSorin、F. Hoffmann-La Roche、Siemens Healthineers)
・結論

Immunoprotein is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body system of tissues, organs, cells, or cell products that neutralize antigens. They enable the diagnosis of various diseases, such as cardiovascular, oncology, infectious diseases, and others, as they display an abnormal increase in their concentration when in a diseased state.
The increasing use of immunochromatography-based cassette kits or test strips is estimated to be one of the primary growth drivers for the global immunoprotein diagnostic testing market till 2023. Immunochromatography is the chromatographic method of immunoassay. It follows the lateral flow testing. It helps in the detection of infectious diseases, oncology, and autoimmune diseases using immunoproteins. The principle behind the working of immunochromatography is similar to the enzyme-linked immunosorbent assay (ELISA) test. These tests and reagents will improve the efficiency of diagnosis of diseases. Furthermore, several companies are investing heavily in research and developmental activities to develop products that reduce the time required to generate results.

Market Analysis and Insights: Global Immunoprotein Diagnostic Testing Market
The global Immunoprotein Diagnostic Testing market size is projected to reach US$ 22850 million by 2026, from US$ 15210 million in 2019, at a CAGR of 5.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immunoprotein Diagnostic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immunoprotein Diagnostic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immunoprotein Diagnostic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immunoprotein Diagnostic Testing market.

Global Immunoprotein Diagnostic Testing Scope and Market Size
Immunoprotein Diagnostic Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immunoprotein Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
C-reactive Protein Diagnostic Test
Complement System Protein Diagnostic Test
Prealbumin Diagnostic Test
Haptoglobin Diagnostic Test
Immunoglobulin Diagnostic Test
Free Light Chain Diagnostic Test
Others

Segment by Application
Autoimmune Testing
Infectious Disease Testing
Allergy Testing
Endocrine Testing
Oncology Testing
Toxicology Testing
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Beckman Coulter
DiaSorin
F. Hoffmann-La Roche

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunoprotein Diagnostic Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 C-reactive Protein Diagnostic Test
1.2.3 Complement System Protein Diagnostic Test
1.2.4 Prealbumin Diagnostic Test
1.2.5 Haptoglobin Diagnostic Test
1.2.6 Immunoglobulin Diagnostic Test
1.2.7 Free Light Chain Diagnostic Test
1.2.8 Others
1.3 Market by Application
1.3.1 Global Immunoprotein Diagnostic Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Autoimmune Testing
1.3.3 Infectious Disease Testing
1.3.4 Allergy Testing
1.3.5 Endocrine Testing
1.3.6 Oncology Testing
1.3.7 Toxicology Testing
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Immunoprotein Diagnostic Testing Market Perspective (2016-2027)
2.2 Immunoprotein Diagnostic Testing Growth Trends by Regions
2.2.1 Immunoprotein Diagnostic Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immunoprotein Diagnostic Testing Historic Market Share by Regions (2016-2021)
2.2.3 Immunoprotein Diagnostic Testing Forecasted Market Size by Regions (2022-2027)
2.3 Immunoprotein Diagnostic Testing Industry Dynamic
2.3.1 Immunoprotein Diagnostic Testing Market Trends
2.3.2 Immunoprotein Diagnostic Testing Market Drivers
2.3.3 Immunoprotein Diagnostic Testing Market Challenges
2.3.4 Immunoprotein Diagnostic Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Immunoprotein Diagnostic Testing Players by Revenue
3.1.1 Global Top Immunoprotein Diagnostic Testing Players by Revenue (2016-2021)
3.1.2 Global Immunoprotein Diagnostic Testing Revenue Market Share by Players (2016-2021)
3.2 Global Immunoprotein Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immunoprotein Diagnostic Testing Revenue
3.4 Global Immunoprotein Diagnostic Testing Market Concentration Ratio
3.4.1 Global Immunoprotein Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunoprotein Diagnostic Testing Revenue in 2020
3.5 Immunoprotein Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Immunoprotein Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Immunoprotein Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Immunoprotein Diagnostic Testing Breakdown Data by Type
4.1 Global Immunoprotein Diagnostic Testing Historic Market Size by Type (2016-2021)
4.2 Global Immunoprotein Diagnostic Testing Forecasted Market Size by Type (2022-2027)

5 Immunoprotein Diagnostic Testing Breakdown Data by Application
5.1 Global Immunoprotein Diagnostic Testing Historic Market Size by Application (2016-2021)
5.2 Global Immunoprotein Diagnostic Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Immunoprotein Diagnostic Testing Market Size (2016-2027)
6.2 North America Immunoprotein Diagnostic Testing Market Size by Type
6.2.1 North America Immunoprotein Diagnostic Testing Market Size by Type (2016-2021)
6.2.2 North America Immunoprotein Diagnostic Testing Market Size by Type (2022-2027)
6.2.3 North America Immunoprotein Diagnostic Testing Market Size by Type (2016-2027)
6.3 North America Immunoprotein Diagnostic Testing Market Size by Application
6.3.1 North America Immunoprotein Diagnostic Testing Market Size by Application (2016-2021)
6.3.2 North America Immunoprotein Diagnostic Testing Market Size by Application (2022-2027)
6.3.3 North America Immunoprotein Diagnostic Testing Market Size by Application (2016-2027)
6.4 North America Immunoprotein Diagnostic Testing Market Size by Country
6.4.1 North America Immunoprotein Diagnostic Testing Market Size by Country (2016-2021)
6.4.2 North America Immunoprotein Diagnostic Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Immunoprotein Diagnostic Testing Market Size (2016-2027)
7.2 Europe Immunoprotein Diagnostic Testing Market Size by Type
7.2.1 Europe Immunoprotein Diagnostic Testing Market Size by Type (2016-2021)
7.2.2 Europe Immunoprotein Diagnostic Testing Market Size by Type (2022-2027)
7.2.3 Europe Immunoprotein Diagnostic Testing Market Size by Type (2016-2027)
7.3 Europe Immunoprotein Diagnostic Testing Market Size by Application
7.3.1 Europe Immunoprotein Diagnostic Testing Market Size by Application (2016-2021)
7.3.2 Europe Immunoprotein Diagnostic Testing Market Size by Application (2022-2027)
7.3.3 Europe Immunoprotein Diagnostic Testing Market Size by Application (2016-2027)
7.4 Europe Immunoprotein Diagnostic Testing Market Size by Country
7.4.1 Europe Immunoprotein Diagnostic Testing Market Size by Country (2016-2021)
7.4.2 Europe Immunoprotein Diagnostic Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Immunoprotein Diagnostic Testing Market Size (2016-2027)
8.2 Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Type
8.2.1 Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Application
8.3.1 Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Region
8.4.1 Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Immunoprotein Diagnostic Testing Market Size (2016-2027)
9.2 Latin America Immunoprotein Diagnostic Testing Market Size by Type
9.2.1 Latin America Immunoprotein Diagnostic Testing Market Size by Type (2016-2021)
9.2.2 Latin America Immunoprotein Diagnostic Testing Market Size by Type (2022-2027)
9.2.3 Latin America Immunoprotein Diagnostic Testing Market Size by Type (2016-2027)
9.3 Latin America Immunoprotein Diagnostic Testing Market Size by Application
9.3.1 Latin America Immunoprotein Diagnostic Testing Market Size by Application (2016-2021)
9.3.2 Latin America Immunoprotein Diagnostic Testing Market Size by Application (2022-2027)
9.3.3 Latin America Immunoprotein Diagnostic Testing Market Size by Application (2016-2027)
9.4 Latin America Immunoprotein Diagnostic Testing Market Size by Country
9.4.1 Latin America Immunoprotein Diagnostic Testing Market Size by Country (2016-2021)
9.4.2 Latin America Immunoprotein Diagnostic Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Immunoprotein Diagnostic Testing Market Size (2016-2027)
10.2 Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Type
10.2.1 Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Application
10.3.1 Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Country
10.4.1 Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Beckman Coulter
11.1.1 Beckman Coulter Company Details
11.1.2 Beckman Coulter Business Overview
11.1.3 Beckman Coulter Immunoprotein Diagnostic Testing Introduction
11.1.4 Beckman Coulter Revenue in Immunoprotein Diagnostic Testing Business (2016-2021)
11.1.5 Beckman Coulter Recent Development
11.2 DiaSorin
11.2.1 DiaSorin Company Details
11.2.2 DiaSorin Business Overview
11.2.3 DiaSorin Immunoprotein Diagnostic Testing Introduction
11.2.4 DiaSorin Revenue in Immunoprotein Diagnostic Testing Business (2016-2021)
11.2.5 DiaSorin Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Immunoprotein Diagnostic Testing Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Immunoprotein Diagnostic Testing Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Immunoprotein Diagnostic Testing Introduction
11.4.4 Siemens Healthineers Revenue in Immunoprotein Diagnostic Testing Business (2016-2021)
11.4.5 Siemens Healthineers Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Immunoprotein Diagnostic Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of C-reactive Protein Diagnostic Test
Table 3. Key Players of Complement System Protein Diagnostic Test
Table 4. Key Players of Prealbumin Diagnostic Test
Table 5. Key Players of Haptoglobin Diagnostic Test
Table 6. Key Players of Immunoglobulin Diagnostic Test
Table 7. Key Players of Free Light Chain Diagnostic Test
Table 8. Key Players of Others
Table 9. Global Immunoprotein Diagnostic Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Immunoprotein Diagnostic Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Immunoprotein Diagnostic Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Immunoprotein Diagnostic Testing Market Share by Regions (2016-2021)
Table 13. Global Immunoprotein Diagnostic Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Immunoprotein Diagnostic Testing Market Share by Regions (2022-2027)
Table 15. Immunoprotein Diagnostic Testing Market Trends
Table 16. Immunoprotein Diagnostic Testing Market Drivers
Table 17. Immunoprotein Diagnostic Testing Market Challenges
Table 18. Immunoprotein Diagnostic Testing Market Restraints
Table 19. Global Immunoprotein Diagnostic Testing Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Immunoprotein Diagnostic Testing Market Share by Players (2016-2021)
Table 21. Global Top Immunoprotein Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunoprotein Diagnostic Testing as of 2020)
Table 22. Ranking of Global Top Immunoprotein Diagnostic Testing Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Immunoprotein Diagnostic Testing Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Immunoprotein Diagnostic Testing Product Solution and Service
Table 26. Date of Enter into Immunoprotein Diagnostic Testing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Immunoprotein Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Immunoprotein Diagnostic Testing Revenue Market Share by Type (2016-2021)
Table 30. Global Immunoprotein Diagnostic Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Immunoprotein Diagnostic Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Immunoprotein Diagnostic Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Immunoprotein Diagnostic Testing Revenue Market Share by Application (2016-2021)
Table 34. Global Immunoprotein Diagnostic Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Immunoprotein Diagnostic Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Immunoprotein Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Immunoprotein Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Immunoprotein Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Immunoprotein Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Immunoprotein Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Immunoprotein Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Immunoprotein Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Immunoprotein Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Immunoprotein Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Immunoprotein Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Immunoprotein Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Immunoprotein Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Immunoprotein Diagnostic Testing Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Immunoprotein Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Immunoprotein Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Immunoprotein Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Immunoprotein Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Immunoprotein Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Immunoprotein Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Immunoprotein Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 66. Beckman Coulter Company Details
Table 67. Beckman Coulter Business Overview
Table 68. Beckman Coulter Immunoprotein Diagnostic Testing Product
Table 69. Beckman Coulter Revenue in Immunoprotein Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 70. Beckman Coulter Recent Development
Table 71. DiaSorin Company Details
Table 72. DiaSorin Business Overview
Table 73. DiaSorin Immunoprotein Diagnostic Testing Product
Table 74. DiaSorin Revenue in Immunoprotein Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 75. DiaSorin Recent Development
Table 76. F. Hoffmann-La Roche Company Details
Table 77. F. Hoffmann-La Roche Business Overview
Table 78. F. Hoffmann-La Roche Immunoprotein Diagnostic Testing Product
Table 79. F. Hoffmann-La Roche Revenue in Immunoprotein Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 80. F. Hoffmann-La Roche Recent Development
Table 81. Siemens Healthineers Company Details
Table 82. Siemens Healthineers Business Overview
Table 83. Siemens Healthineers Immunoprotein Diagnostic Testing Product
Table 84. Siemens Healthineers Revenue in Immunoprotein Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 85. Siemens Healthineers Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunoprotein Diagnostic Testing Market Share by Type: 2020 VS 2027
Figure 2. C-reactive Protein Diagnostic Test Features
Figure 3. Complement System Protein Diagnostic Test Features
Figure 4. Prealbumin Diagnostic Test Features
Figure 5. Haptoglobin Diagnostic Test Features
Figure 6. Immunoglobulin Diagnostic Test Features
Figure 7. Free Light Chain Diagnostic Test Features
Figure 8. Others Features
Figure 9. Global Immunoprotein Diagnostic Testing Market Share by Application: 2020 VS 2027
Figure 10. Autoimmune Testing Case Studies
Figure 11. Infectious Disease Testing Case Studies
Figure 12. Allergy Testing Case Studies
Figure 13. Endocrine Testing Case Studies
Figure 14. Oncology Testing Case Studies
Figure 15. Toxicology Testing Case Studies
Figure 16. Others Case Studies
Figure 17. Immunoprotein Diagnostic Testing Report Years Considered
Figure 18. Global Immunoprotein Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global Immunoprotein Diagnostic Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Immunoprotein Diagnostic Testing Market Share by Regions: 2020 VS 2027
Figure 21. Global Immunoprotein Diagnostic Testing Market Share by Regions (2022-2027)
Figure 22. Global Immunoprotein Diagnostic Testing Market Share by Players in 2020
Figure 23. Global Top Immunoprotein Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunoprotein Diagnostic Testing as of 2020
Figure 24. The Top 10 and 5 Players Market Share by Immunoprotein Diagnostic Testing Revenue in 2020
Figure 25. Global Immunoprotein Diagnostic Testing Revenue Market Share by Type (2016-2021)
Figure 26. Global Immunoprotein Diagnostic Testing Revenue Market Share by Type (2022-2027)
Figure 27. North America Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America Immunoprotein Diagnostic Testing Market Share by Type (2016-2027)
Figure 29. North America Immunoprotein Diagnostic Testing Market Share by Application (2016-2027)
Figure 30. North America Immunoprotein Diagnostic Testing Market Share by Country (2016-2027)
Figure 31. United States Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Immunoprotein Diagnostic Testing Market Share by Type (2016-2027)
Figure 35. Europe Immunoprotein Diagnostic Testing Market Share by Application (2016-2027)
Figure 36. Europe Immunoprotein Diagnostic Testing Market Share by Country (2016-2027)
Figure 37. Germany Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Immunoprotein Diagnostic Testing Market Share by Type (2016-2027)
Figure 45. Asia-Pacific Immunoprotein Diagnostic Testing Market Share by Application (2016-2027)
Figure 46. Asia-Pacific Immunoprotein Diagnostic Testing Market Share by Region (2016-2027)
Figure 47. China Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Immunoprotein Diagnostic Testing Market Share by Type (2016-2027)
Figure 55. Latin America Immunoprotein Diagnostic Testing Market Share by Application (2016-2027)
Figure 56. Latin America Immunoprotein Diagnostic Testing Market Share by Country (2016-2027)
Figure 57. Mexico Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Immunoprotein Diagnostic Testing Market Share by Type (2016-2027)
Figure 61. Middle East & Africa Immunoprotein Diagnostic Testing Market Share by Application (2016-2027)
Figure 62. Middle East & Africa Immunoprotein Diagnostic Testing Market Share by Country (2016-2027)
Figure 63. Turkey Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE Immunoprotein Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. Beckman Coulter Revenue Growth Rate in Immunoprotein Diagnostic Testing Business (2016-2021)
Figure 67. DiaSorin Revenue Growth Rate in Immunoprotein Diagnostic Testing Business (2016-2021)
Figure 68. F. Hoffmann-La Roche Revenue Growth Rate in Immunoprotein Diagnostic Testing Business (2016-2021)
Figure 69. Siemens Healthineers Revenue Growth Rate in Immunoprotein Diagnostic Testing Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed